Philip receives ESGCT Young Investigator Award 🎉
vor 5 Stunden
1 Min. Lesezeit
At this year’s 33rd Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) in Hamburg, Philip was awarded the Zelig Eshar Adoptive T-cell Therapy Young Investigator Award for his talk on ROADSTAR—our approach to fine-tuning CAR T-cell signaling for improved persistence and anti-tumor activity.

Many thanks to the ESGCT organizers for a great meeting, as well as to the Cluster of Excellence iFIT for their support.
Congratulations, Philip! 🎉


